Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-04-25 Capital/Financing Update
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare AS: Proposed partially underwritten rights issue
Capital/Financing Update Classification · 1% confidence The document is titled "LIFECARE AS: PROPOSED PARTIALLY UNDERWRITTEN RIGHTS ISSUE" and details a plan to increase share capital through the issuance of new shares via a rights issue, including details on underwriting, warrants, subscription price, and an indicative timeline. This clearly describes a corporate action related to fundraising and capital structure changes. This aligns directly with the definition for Capital/Financing Update (CAP). Although it mentions a future Prospectus and EGM, the core content is the announcement of the financing proposal itself, not just the announcement of the report (RPA) or the final voting results (DVA).
2024-04-25 English
Lifecare AS: Proposed partially underwritten rights issue
Capital/Financing Update Classification · 1% confidence The document explicitly announces a 'Proposed partially underwritten rights issue' by Lifecare AS, detailing the intention to increase share capital, the minimum and maximum gross proceeds (NOK 75 million to NOK 90 million), the involvement of underwriters, and the issuance of warrants. This content directly relates to fundraising, financing activities, and changes to the capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions a future Prospectus and EGM, the core subject is the capital raise itself, not just the announcement of a report (RPA) or a general regulatory filing (RNS).
2024-04-25 English
Annual General Meeting
AGM Information Classification · 1% confidence The document is titled "Innkalling til Ordinær Generalforsamling" (Notice of Annual General Meeting) and includes a detailed agenda for a meeting scheduled for April 30, 2024. Key agenda items include approval of annual accounts, authorization for capital increases, and election of the board/auditor. This content directly relates to the formal proceedings and materials distributed for an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The document length is short (2762 chars), but it is the notice/agenda itself, not just an announcement that materials are available, making AGM-R more specific than RPA or RNS.
2024-04-16 Norwegian
Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states 'ANNUAL GENERAL MEETING' and provides details about the date, time, and method of participation (physical and digital) for the meeting. It also mentions that the full agenda and documents are available elsewhere. This content directly relates to the scheduling and announcement of the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length is short (1902 chars), but the content is the notice/announcement itself, not just a link, making AGM-R more specific than RPA or RNS.
2024-04-16 English
Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states "Annual General Meeting" as the title and details the date, time, and method of participation for the General Meeting (April 30th, 2024). This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions that full agenda and documents are available elsewhere, the core content is the announcement and details of the meeting itself, making AGM-R the most appropriate classification over RPA or RNS.
2024-04-16 English
LIFE: Presentation at MARSS 2024
Regulatory Filings Classification · 1% confidence The document is a short announcement, dated April 16, 2024, titled 'LIFE: PRESENTATION AT MARSS 2024' and explicitly labeled as a 'PRESS RELEASE'. It details that a company employee is invited to present a paper at an international conference (MARSS 2024). This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a presentation (IP) or a management change (MANG). It is a general announcement about company activity, specifically related to scientific/technical achievements and participation in an external event. Since it doesn't fit the specific categories like AGM-R, DIRS, DIV, etc., and it is a general press release, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory/public disclosure.
2024-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.